Journal of Biological Chemistry
Volume 281, Issue 37, 15 September 2006, Pages 26854-26864
Journal home page for Journal of Biological Chemistry

Glycobiology and Extracellular Matrices
Lectin from the Manila Clam Ruditapes philippinarum Is Induced upon Infection with the Protozoan Parasite Perkinsus olseni*

https://doi.org/10.1074/jbc.M601251200Get rights and content
Under a Creative Commons license
open access

Glycan-binding proteins (lectins) are widely expressed in many invertebrates, although the biosynthesis and functions of the lectins are not well understood. Here we report that Manila clam (Ruditapes philippinarum) synthesizes a lectin termed Manila clam lectin (MCL) upon infection with the protozoan parasite Perkinsus olseni. MCL is synthesized in hemocytes as a ∼74-kDa precursor and secreted into hemolymph where it is converted to 30and 34-kDa polypeptides. The synthesis of MCL in hemocytes is stimulated by one or more factors in Perkinsus-infected hemolymph, but not directly by Perkinsus itself. MCL can bind to the surfaces of purified hypnospores and zoospores of the parasite, and this binding is inhibitable by either EDTA or GalNAc. Fluorescent beads coated with purified MCL were actively phagocytosed by hemocytes from the clam. Immunohistochemistry showed that secreted MCL is concentrated within cyst-like structures. To define the glycan binding specificity of MCL we examined its binding to an array of biotinylated glycans. MCL recognizes terminal non-reducing β-linked GalNAc as expressed within the LacdiNAc motif GalNAcβ1–4GlcNAcβ1-R and glycans with terminal, non-reducing β-linked Gal residues. Our results show that the synthesis of MCL is specifically up-regulated upon parasite infection of the clams and may serve as an opsonin through recognition of terminal GalNAc/Gal residues on the parasites.

Cited by (0)

3

W. S. Rasband (1997–2006) ImageJ, National Institutes of Health, Bethesda, MD, rsb.info.nih.gov/ij/.

*

This work was supported by a Korea Research Foundation Grant (KRF-2003-042-F00006), by the Basic Research Program of the Korea Science & Engineering Foundation (Grant R01-2006-000-11316-0), and by NIGMS, National Institutes of Health Grant GM62116 to the Consortium for Functional Glycomics. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.